ACNB vs GUG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ACNB presents a compelling value opportunity with a Piotroski F-Score of 4/9 indicating stable financial health and a current price ($49.74) trading significantly below both its Graham Number ($57.27) and Intrinsic Value ($106.2). The company is exhibiting exceptional growth metrics, with YoY revenue and earnings growth both exceeding 34%, paired with a very attractive forward P/E of 9.62. While technical trends are currently bearish and insider sentiment is neutral, the fundamental disconnect between the stock's price and its growth trajectory suggests significant upside potential.
GUG exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health. The asset is trading at a significant premium to its growth-based intrinsic value of $8.96, while the dividend payout ratio of 111.33% suggests an unsustainable distribution policy. Despite positive long-term price performance, current technical trends are bearish and insider activity is negative. The combination of a failing health scorecard and overvaluation makes this a high-risk position.
Compare Another Pair
Related Comparisons
ACNB vs GUG: Head-to-Head Comparison
This page compares ACNB Corporation (ACNB) and Guggenheim Active Allocation Fund (GUG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.